Reddit has become a peer-review layer for peptide certificates of analysis. Users zoom into chromatograms, compare mass spectra, call laboratories, and look for reused report numbers. That skepticism is useful, but a technically real COA can still be misunderstood.
The central mistake is treating a high HPLC area percentage as a universal quality score. It may describe the proportion of detected chromatographic peaks under one method. It does not automatically establish total vial content, sequence confirmation, counterions, residual solvents, aggregation, sterility, endotoxin, particulate matter, or stability.
The six questions a COA should not collapse
- Identity: is the material the intended molecule and sequence?
- Assay or content: how much active material is actually present?
- Purity and related substances: what impurities are detected and how are they quantified?
- Physical and chemical quality: water, counterions, residual solvents, pH, aggregation, and particles as relevant.
- Microbiological quality: sterility, bioburden, and bacterial endotoxin for the intended route.
- Stability: does the product remain within specification through storage and use?
Why “99% purity” can coexist with the wrong amount
A chromatogram can show that most detected peak area belongs to one component while the vial is underfilled, contains water or salts not captured by that number, or has an identity problem the method cannot resolve. Mass spectrometry can support molecular-mass identity but may not fully establish sequence, isomers, or all relevant impurities.
A 2024 study that ordered semaglutide products from illegal online pharmacies found major quality problems in tested samples, including measured purity far below advertised claims and content discrepancies. The small sample does not describe every seller, but it demonstrates why website claims and labels are not enough.
Audit the report, the lab, and the chain of custody
Look for a unique report number, sample description, received and tested dates, method references, acceptance criteria, actual results, units, signatures, and laboratory contact information. Confirm that the lab offers the method and, where relevant, has accreditation within the claimed scope.
Then ask who selected and submitted the sample. Vendor-submitted testing can be real but does not provide independent random sampling. A report can also be reused for another lot, digitally altered, or linked to inventory that was never sampled.
No COA proves suitability for human use by itself
A document can reduce one uncertainty. It cannot replace an approved supply chain, validated manufacturing process, batch records, stability program, inspection history, pharmacovigilance, and clinician oversight.
Red flags in a Reddit COA post
- Only a cropped purity number is visible, with no sample identity, date, method, or report number.
- The lot on the vial does not match the report, or no lot is shown.
- “Third-party tested” means the vendor chose and mailed the sample but that limitation is not disclosed.
- Sterility or endotoxin is implied from HPLC or mass spectrometry.
- The laboratory cannot verify the report or the method is outside its stated scope.
- The same report appears across changing lots, products, or vendors.
How to make your tracking more useful
Strong personal logs begin with a short baseline and keep the same measurements long enough for a pattern to emerge. Peptify can connect dates, context, and observations locally on your device so the record is more useful than memory alone.
- Product, vendor, lot, report number, laboratory, sample date, and who submitted the sample.
- Identity method, assay or content, purity method, impurity results, sterility, endotoxin, and stability claims.
- Temperature history, seal condition, reconstitution observations, and any adverse event linked to the lot.
See the N-of-1 tracking guide and visual tracking guide for a reproducible setup.
Questions to discuss with a healthcare practitioner
- Which quality attributes matter for the intended route and formulation?
- Can a pharmacist or analytical specialist interpret the methods, specifications, and missing tests?
- Does the product come through an approved or otherwise lawful, accountable supply chain with adverse-event reporting?